A national survey on knowledge and perceptions of senior medical students in Australia about generic medicines

Mohamed Azmi Ahmad Hassali, Kay Stewart and David C M Kong
Med J Aust 2008; 188 (2): . || doi: 10.5694/j.1326-5377.2008.tb01543.x
Published online: 21 January 2008

To the Editor: In Australia, the rising cost of the Pharmaceutical Benefits Scheme (a comprehensive system for subsidising prescription medicines for the whole population) has led to the Australian Government instituting a number of cost-saving strategies.

  • 1 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • 2 Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Melbourne, VIC.


  • 1. McGavock H. Generic substitution: issues relating to the Australian experience. Pharmacoepidemiol Drug Saf 2001; 10: 555-556.
  • 2. Birkett DJ. Generics — equal or not? Aust Prescr 2003; 26: 85-87.
  • 3. Salmivaara AH, Huupponen R, Klaukka T, Hoppu K. Focusing on changing clinical practice to enhance rational prescribing — collaboration and networking enable comprehensive approaches. Health Policy 2003; 66: 1-10.
  • 4. Armstrong D, Reyburn H, Jones R. A study of general practitioners’ reasons for changing their prescribing behaviour. BMJ 1996; 312: 949-952.
  • 5. Majumdar SR, Tsuyuki RT, McAlister FA. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial. Am Heart J 2007; 153: 22e1-22e8.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.